SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-030577
Filing Date
2020-10-08
Accepted
2020-10-08 07:08:51
Documents
14
Period of Report
2020-10-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea127978-8k_intecpharma.htm   iXBRL 8-K 24256
2 PRESS RELEASE ISSUED BY INTEC PHARMA LTD. ON OCTOBER 8, 2020 ea127978ex99-1_intec.htm EX-99.1 6750
  Complete submission text file 0001213900-20-030577.txt   176537

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ntec-20201008.xsd EX-101.SCH 3442
4 XBRL DEFINITION FILE ntec-20201008_def.xml EX-101.DEF 11083
5 XBRL LABEL FILE ntec-20201008_lab.xml EX-101.LAB 22423
6 XBRL PRESENTATION FILE ntec-20201008_pre.xml EX-101.PRE 11486
7 EXTRACTED XBRL INSTANCE DOCUMENT ea127978-8k_intecpharma_htm.xml XML 2554
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 201230101
SIC: 2834 Pharmaceutical Preparations